Tirzepatide
A dual GIP/GLP-1 receptor agonist used in comparative incretin-pathway research.
Select size
Purchase type
Independently tested — batch AXN-TIRZ-26088
Cold-chain packed, ships within 24 hours
View Certificate of Analysis (COA)For laboratory research use only. Not for human or veterinary use. By purchasing, you certify you are 21+ and a qualified researcher.
Tirzepatide is a synthetic 39-amino-acid peptide engineered to activate both the GIP and GLP-1 receptors, making it a common reference compound in dual-incretin agonism studies.
Laboratories use tirzepatide to compare single- versus dual-agonist receptor engagement in transfected cell lines and to benchmark novel analogs during early-stage discovery work.
Supplied as a high-purity lyophilized powder with full batch documentation for traceability across a research program.
Tirzepatide
$159.00 · 10 mg